Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics
about
Identification of novel biomarker and therapeutic target candidates for acute intracerebral hemorrhage by quantitative plasma proteomics.Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings.Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.Identification of Apolipoprotein A-I as a Retinoic Acid-binding Protein in the Eye.Novel "omics" approach for study of low-abundance, low-molecular-weight components of a complex biological tissue: regional differences between chorionic and basal plates of the human placenta.Identification of Plasma Membrane Glycoproteins Specific to Human Glioblastoma Multiforme Cells Using Lectin Arrays and LC-MS/MS.Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency.Loss of heterozygosity and uniparental disomy of chromosome region 10q23.3-26.3 in glioblastoma.Comparison of sample preparation techniques for large-scale proteomics.
P2860
Q33608614-107EEC47-51F6-4D7D-B376-6006EE510668Q33683844-7D2D5CFF-6E11-4667-A1DD-15D944AB3993Q36481310-1168317E-F831-4241-9BF4-5D5F4FCD68E4Q37295490-F9556659-AED2-4093-88BC-8E47FF41F6EDQ38731795-2E586A89-F85F-4ABC-8619-20BF9BBFBBB5Q39611495-DFC27DF7-CD97-4263-B531-B2ACD1F7631AQ40561932-B37E4BD2-0F6D-43C6-8CA4-5A644900ECB0Q47349973-1856DCFD-E016-4770-BB7A-16EA6F4B54C3Q47852896-0692FD39-1044-42EA-A811-6B47EEE0F75DQ48091842-824FA28D-536F-4E7C-8B0F-2725A54185CFQ51319806-3E57315B-0A1E-4CB5-8C27-2066CD1B9F6E
P2860
Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Comprehensive characterization ...... l-free quantitative proteomics
@ast
Comprehensive characterization ...... l-free quantitative proteomics
@en
type
label
Comprehensive characterization ...... l-free quantitative proteomics
@ast
Comprehensive characterization ...... l-free quantitative proteomics
@en
prefLabel
Comprehensive characterization ...... l-free quantitative proteomics
@ast
Comprehensive characterization ...... l-free quantitative proteomics
@en
P2093
P2860
P1476
Comprehensive characterization ...... l-free quantitative proteomics
@en
P2093
Elizabeth J Cochran
Jennifer M Connelly
Kathleen M Schmainda
Mark G Malkin
Marla A Chesnik
Maxime S Heroux
Mona Al-Gizawiy
Peter S LaViolette
Scott D Rand
Shama P Mirza
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00034.2014
P577
2014-05-06T00:00:00Z